Cardiff Oncology (CRDF) Leases (2019 - 2025)
Cardiff Oncology (CRDF) has disclosed Leases for 7 consecutive years, with $629000.0 as the latest value for Q4 2025.
- Quarterly Leases fell 46.19% to $629000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $629000.0 through Dec 2025, down 46.19% year-over-year, with the annual reading at $629000.0 for FY2025, 46.19% down from the prior year.
- Leases hit $629000.0 in Q4 2025 for Cardiff Oncology, down from $764000.0 in the prior quarter.
- In the past five years, Leases ranged from a high of $3.0 million in Q3 2021 to a low of $178000.0 in Q2 2021.
- Historically, Leases has averaged $1.6 million across 5 years, with a median of $1.6 million in 2023.
- Biggest five-year swings in Leases: crashed 64.53% in 2021 and later surged 1317.98% in 2022.
- Year by year, Leases stood at $2.8 million in 2021, then decreased by 19.49% to $2.3 million in 2022, then fell by 24.12% to $1.7 million in 2023, then plummeted by 31.56% to $1.2 million in 2024, then crashed by 46.19% to $629000.0 in 2025.
- Business Quant data shows Leases for CRDF at $629000.0 in Q4 2025, $764000.0 in Q3 2025, and $899000.0 in Q2 2025.